奧園健康(03662.HK)逆市續升逾半成 市前有涉資3億元大手上板
內地物管股奧園健康(03662.HK)今早市前有一宗5,000萬股以每股6元(較昨天收市價折讓3.2%)非自動對盤上板,涉資3億元,該股今早跑贏同業,曾一舉重越10天及20天線(6.65元及6.44元),最高見6.8元,現造6.53元,續升5.3%,成交增至6,850萬股,涉資逾4.21億元。
奧園健康上周初公布,去年純利倍增至1.62億人民幣(下同),每股盈利23.78分,末期股息按年增63.6%至9分。期內,總收入按年升45.6%至9.01億元;毛利按年升61.5%至3.37億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.